MLYS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 33.24%

Insider Buying (Last 12 Months): $25,599,996.00

Insider Selling (Last 12 Months): $10,205,734.74

Mineralys Therapeutics Insider Trading History Chart

Mineralys Therapeutics Share Price & Price History

^$16.17

▼ -0.7 (-4.15%)

As of 03/24/2025 05:00 PM ET

Days: 30 | 90 | 365

Mineralys Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/13/2025	Ra Capital Management, L.P.	Director	Buy	1,296,296	$13.50	$17,499,996.00	4,280,051
3/13/2025	Samsara Biocapital Gp, Llc	Major Shareholder	Buy	600,000	$13.50	$8,100,000.00	5,674,916
1/13/2025	Adam Scott Levy	CFO	Sell	10,757	$9.10	$97,888.70	226,097
1/13/2025	Jon Congleton	CEO	Sell	18,333	$9.06	$166,096.98	877,608
11/6/2024	David Malcom Rodman	Insider	Sell	25,482	$15.03	$382,994.46	135,974
10/11/2024	Adam Scott Levy	CFO	Sell	10,757	$13.57	$145,972.49	236,854
10/11/2024	Jon Congleton	CEO	Sell	15,271	$13.52	$206,463.92	895,941
7/24/2024	Brian Taylor Slingsby	Director	Sell	550,000	$13.05	$7,177,500.00	8,644,579
7/16/2024	David Malcom Rodman	Insider	Sell	525	$15.00	$7,875.00	102,873
7/11/2024	Adam Scott Levy	CFO	Sell	10,757	$13.14	$141,346.98	247,611
7/11/2024	Jon Congleton	CEO	Sell	15,746	$13.34	$210,051.64	911,212
6/14/2024	Jon Congleton	CEO	Sell	16,229	$12.52	$203,187.08	976,271
6/12/2024	Jon Congleton	CEO	Sell	16,607	$12.77	$212,071.39	1,032,461
6/11/2024	Adam Scott Levy	CFO	Sell	96,815	$12.94	$1,252,786.10	255,462
5/9/2024	David Malcom Rodman	Insider	Sell	100	$15.00	$1,500.00	66,997
2/12/2024	Samsara Biocapital Gp, Llc	Major Shareholder	Buy	555,555	$13.50	$7,499,992.50	5,074,916
11/22/2023	Jon Congleton	CEO	Buy	4,250	$5.97	$25,372.50	1,049,068
9/6/2023	Jon Congleton	CEO	Buy	2,250	$12.08	$27,180.00	1,044,818
8/17/2023	Jon Congleton	CEO	Buy	2,250	$12.10	$27,225.00	1,042,568
8/11/2023	David Malcom Rodman	insider	Sell	157,091	$12.81	$2,012,335.71
8/11/2023	Jon Congleton	CEO	Buy	2,000	$12.89	$25,780.00	1,040,318
2/14/2023	Adam Scott Levy	CFO	Buy	6,250	$16.00	$100,000.00	350,811
2/14/2023	Hbm Healthcare Investments (Ca	Major Shareholder	Buy	312,500	$16.00	$5,000,000.00	3,218,106
2/14/2023	Ra Capital Management, L.P.	Director	Buy	1,250,000	$16.00	$20,000,000.00	1,867,229

See Full Table

SEC Filings (Institutional Ownership Changes) for Mineralys Therapeutics (NASDAQ:MLYS)

84.46% of Mineralys Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Mineralys Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	91,529	$1.13M	0.0%	+43.0%	0.146%
2/25/2025	Polar Asset Management Partners Inc.	99,100	$1.22M	0.0%	+144.7%	0.199%
2/17/2025	Tema Etfs LLC	89,529	$1.10M	0.5%	N/A	0.180%
2/17/2025	Stempoint Capital LP	400,101	$4.93M	1.2%	N/A	0.804%
2/17/2025	Sphera Funds Management LTD.	190,672	$2.35M	0.4%	-30.0%	0.383%
2/17/2025	Polar Asset Management Partners Inc.	99,100	$1.22M	0.0%	+144.7%	0.199%
2/17/2025	ProShare Advisors LLC	10,405	$0.13M	0.0%	N/A	0.021%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	28,068	$0.35M	0.0%	-9.7%	0.056%
2/17/2025	Orbimed Advisors LLC	1,611,637	$19.84M	0.4%	-19.5%	3.238%
2/17/2025	Millennium Management LLC	1,101,674	$13.56M	0.0%	+1,015.8%	2.214%
2/17/2025	Letko Brosseau & Associates Inc.	16,500	$0.20M	0.0%	+44.7%	0.033%
2/17/2025	Integral Health Asset Management LLC	875,000	$10.77M	0.9%	+145.8%	1.758%
2/17/2025	Deutsche Bank AG	26,732	$0.33M	0.0%	+62.3%	0.054%
2/17/2025	Balyasny Asset Management L.P.	17,786	$0.22M	0.0%	N/A	0.036%
2/17/2025	Bank of America Corp DE	107,703	$1.33M	0.0%	+12.0%	0.216%
2/17/2025	BNP Paribas Financial Markets	3,895	$48K	0.0%	N/A	0.008%
2/17/2025	Adams Street Partners LLC	1,129,807	$13.91M	12.3%	-26.3%	2.270%
2/14/2025	Caligan Partners LP	1,011,155	$12.45M	3.3%	+3.1%	2.032%
2/14/2025	Northern Trust Corp	246,113	$3.03M	0.0%	+0.7%	0.495%
2/14/2025	Boothbay Fund Management LLC	650,023	$8M	0.2%	+7.3%	1.306%
2/14/2025	Virtus ETF Advisers LLC	5,842	$72K	0.0%	-19.6%	0.012%
2/14/2025	Price T Rowe Associates Inc. MD	11,715	$0.15M	0.0%	N/A	0.024%
2/14/2025	Dimensional Fund Advisors LP	16,412	$0.20M	0.0%	N/A	0.033%
2/13/2025	Barclays PLC	46,396	$0.57M	0.0%	+21.4%	0.093%
2/13/2025	Renaissance Technologies LLC	119,500	$1.47M	0.0%	+15.1%	0.240%
2/13/2025	ADAR1 Capital Management LLC	841,541	$10.36M	2.1%	+15.4%	1.691%
2/13/2025	Federated Hermes Inc.	15,516	$0.19M	0.0%	-7.9%	0.031%
2/13/2025	Wells Fargo & Company MN	23,714	$0.29M	0.0%	+19.1%	0.048%
2/12/2025	Wellington Management Group LLP	91,529	$1.13M	0.0%	+43.0%	0.184%
2/12/2025	NEOS Investment Management LLC	89,529	$1.10M	0.0%	-27.5%	0.180%
2/12/2025	JPMorgan Chase & Co.	503,590	$6.20M	0.0%	+2,251.5%	1.012%
2/11/2025	EntryPoint Capital LLC	12,487	$0.15M	0.1%	N/A	0.025%
2/11/2025	Prudential Financial Inc.	125,650	$1.55M	0.0%	+85.7%	0.252%
2/11/2025	Corebridge Financial Inc.	14,197	$0.18M	0.0%	-7.0%	0.029%
2/11/2025	Vanguard Group Inc.	1,432,042	$17.63M	0.0%	+5.0%	2.877%
2/11/2025	American Century Companies Inc.	848,630	$10.45M	0.0%	-8.9%	1.705%
2/7/2025	AlphaQuest LLC	15,222	$0.19M	0.0%	+2,637.8%	0.031%
2/7/2025	Candriam S.C.A.	305,272	$3.76M	0.0%	N/A	0.613%
2/6/2025	Proficio Capital Partners LLC	23,192	$0.29M	0.0%	N/A	0.047%
2/6/2025	Charles Schwab Investment Management Inc.	214,906	$2.65M	0.0%	+0.6%	0.432%
2/5/2025	Proficio Capital Partners LLC	23,192	$0.29M	0.0%	N/A	0.047%
2/4/2025	Bank of New York Mellon Corp	65,318	$0.80M	0.0%	+2.7%	0.131%
1/24/2025	Jennison Associates LLC	1,082,006	$13.32M	0.0%	+55.4%	2.174%
1/24/2025	China Universal Asset Management Co. Ltd.	10,553	$0.13M	0.0%	+10.3%	0.021%
1/17/2025	SG Americas Securities LLC	19,961	$0.25M	0.0%	+119.0%	0.040%
11/27/2024	Franklin Resources Inc.	1,745,513	$21.14M	0.0%	+17.7%	3.507%
11/19/2024	Barclays PLC	38,218	$0.46M	0.0%	+281.8%	0.077%
11/16/2024	Geode Capital Management LLC	620,853	$7.52M	0.0%	+6.6%	1.247%
11/15/2024	Barclays PLC	38,218	$0.46M	0.0%	+281.8%	0.077%
11/15/2024	Jane Street Group LLC	15,855	$0.19M	0.0%	-30.4%	0.032%
11/15/2024	Wellington Management Group LLP	63,998	$0.78M	0.0%	N/A	0.129%
11/15/2024	Sphera Funds Management LTD.	272,472	$3.30M	0.5%	-38.5%	0.547%
11/15/2024	State Street Corp	483,766	$5.86M	0.0%	+4.0%	0.972%
11/15/2024	Polar Asset Management Partners Inc.	40,500	$0.49M	0.0%	N/A	0.081%
11/15/2024	Ikarian Capital LLC	180,000	$2.18M	0.3%	N/A	0.362%
11/14/2024	Bellevue Group AG	16,499	$0.20M	0.0%	-5.7%	0.033%
11/14/2024	Caligan Partners LP	981,155	$11.88M	3.8%	+31.6%	1.973%
11/14/2024	PDT Partners LLC	12,238	$0.15M	0.0%	N/A	0.025%
11/14/2024	Verition Fund Management LLC	27,361	$0.33M	0.0%	+30.6%	0.055%
11/14/2024	Martingale Asset Management L P	14,965	$0.18M	0.0%	N/A	0.030%
11/13/2024	FMR LLC	303,758	$3.68M	0.0%	+12.0%	0.611%
11/12/2024	Charles Schwab Investment Management Inc.	213,599	$2.59M	0.0%	+4.7%	0.430%
11/8/2024	Jennison Associates LLC	696,280	$8.43M	0.0%	+1.9%	1.400%
10/25/2024	China Universal Asset Management Co. Ltd.	9,564	$0.12M	0.0%	+64.0%	0.019%
10/3/2024	SG Americas Securities LLC	9,116	$0.11M	0.0%	N/A	0.018%
8/20/2024	Nantahala Capital Management LLC	532,506	$6.23M	0.4%	+60.1%	1.073%
8/16/2024	Driehaus Capital Management LLC	257,371	$3.01M	0.0%	+40.4%	0.518%
8/15/2024	Blue Owl Capital Holdings LP	450,339	$5.27M	1.5%	-16.8%	0.907%
8/15/2024	Lion Point Capital LP	79,000	$0.92M	1.7%	+31.7%	0.159%
8/15/2024	The Manufacturers Life Insurance Company	12,432	$0.15M	0.0%	N/A	0.025%
8/14/2024	Adams Street Partners LLC	1,688,712	$19.76M	8.1%	-10.0%	3.401%
8/9/2024	Renaissance Technologies LLC	61,800	$0.72M	0.0%	+95.0%	0.124%
8/8/2024	Federated Hermes Inc.	12,000	$0.14M	0.0%	+100.0%	0.024%
8/8/2024	American Century Companies Inc.	743,140	$8.70M	0.0%	+3.2%	1.497%
8/1/2024	Rhumbline Advisers	41,079	$0.48M	0.0%	+82.1%	0.083%
7/26/2024	Bank of New York Mellon Corp	84,762	$0.99M	0.0%	+72.5%	0.171%
5/17/2024	RA Capital Management L.P.	4,850,984	$62.63M	0.8%	+52.6%	9.770%
5/16/2024	California State Teachers Retirement System	1,953	$25K	0.0%	-38.9%	0.004%
5/15/2024	Bellevue Group AG	9,200	$0.12M	0.0%	N/A	0.019%
5/15/2024	Affinity Asset Advisors LLC	327,959	$4.23M	0.5%	N/A	0.661%
5/14/2024	EntryPoint Capital LLC	4,632	$60K	0.1%	-30.4%	0.009%
5/14/2024	SR One Capital Management LP	2,016,822	$26.04M	7.2%	+12.4%	4.062%
5/10/2024	Vanguard Group Inc.	982,932	$12.69M	0.0%	+0.5%	1.980%
4/29/2024	China Universal Asset Management Co. Ltd.	7,931	$0.10M	0.0%	+67.0%	0.016%
3/22/2024	PNC Financial Services Group Inc.	4,122	$35K	0.0%	+17,821.7%	0.010%
2/14/2024	Catalys Pacific LLC	9,194,579	$79.07M	74.1%	N/A	22.371%
2/14/2024	Pale Fire Capital SE	34,743	$0.30M	0.0%	N/A	0.085%
2/14/2024	Sectoral Asset Management Inc.	605,606	$5.21M	2.2%	-28.0%	1.473%
2/13/2024	Tower Research Capital LLC TRC	2,879	$25K	0.0%	-71.4%	0.007%
2/13/2024	NEOS Investment Management LLC	23,973	$0.21M	0.0%	N/A	0.058%
2/9/2024	Franklin Resources Inc.	699,467	$6.02M	0.0%	+55.4%	1.702%
2/9/2024	CreativeOne Wealth LLC	10,750	$92K	0.0%	N/A	0.026%
2/7/2024	Jump Financial LLC	20,500	$0.18M	0.0%	-37.3%	0.050%
2/5/2024	Russell Investments Group Ltd.	5,779	$50K	0.0%	-43.2%	0.014%
2/1/2024	CWM LLC	5,891	$51K	0.0%	+120.0%	0.014%
1/31/2024	Federated Hermes Inc.	20,032	$0.17M	0.0%	-10.1%	0.049%
1/30/2024	Cornercap Investment Counsel Inc.	22,209	$0.19M	0.0%	N/A	0.054%
1/24/2024	China Universal Asset Management Co. Ltd.	4,750	$41K	0.0%	N/A	0.012%
1/16/2024	Raymond James Financial Services Advisors Inc.	14,611	$0.13M	0.0%	-64.0%	0.036%
1/12/2024	SG Americas Securities LLC	10,093	$87K	0.0%	N/A	0.025%

Data available starting January 2016

See Full Table

Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and chronic kidney diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone. The company was formerly known as Catalys SC1, Inc. and changed its name to Mineralys Therapeutics, Inc. in May 2020. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.

Today's Range

Now: $16.17

$16.15

$17.35

50 Day Range

MA: $10.86

$8.76

$16.87

52 Week Range

Now: $16.17

$8.24

$18.38

Volume

1,075,966 shs

Average Volume

327,505 shs

Market Capitalization

$1.02 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.5

Who are the company insiders with the largest holdings of Mineralys Therapeutics?: Mineralys Therapeutics' top insider shareholders include:
Brian Taylor Slingsby (Director)
Samsara Biocapital Gp, Llc (Major Shareholder)
Ra Capital Management, LP (Director)
Jon Congleton (CEO)
Adam Scott Levy (CFO)
David Malcom Rodman (Insider)
Learn More about top insider investors at Mineralys Therapeutics.
Who are the major institutional investors of Mineralys Therapeutics?: Mineralys Therapeutics' top institutional investors include:
Orbimed Advisors LLC — 3.24%
Vanguard Group Inc. — 2.88%
Adams Street Partners LLC — 2.27%
Millennium Management LLC — 2.21%
Jennison Associates LLC — 2.17%
Caligan Partners LP — 2.03%
Learn More about top institutional investors of Mineralys Therapeutics stock.
Which major investors are selling Mineralys Therapeutics stock?: In the previous quarter, MLYS stock was sold by these institutional investors:
Adams Street Partners LLC
Orbimed Advisors LLC
American Century Companies Inc.
Sphera Funds Management LTD.
NEOS Investment Management LLC
Citadel Advisors LLC
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC
Virtus ETF Advisers LLC
In the last year, company insiders that have sold Mineralys Therapeutics company stock include:
Brian Taylor Slingsby (Director)
Samsara Biocapital Gp, Llc (Major Shareholder)
Ra Capital Management, LP (Director)
Jon Congleton (CEO)
Learn More investors selling Mineralys Therapeutics stock.
Which major investors are buying Mineralys Therapeutics stock?: During the last quarter, MLYS stock was purchased by institutional investors including:
Millennium Management LLC
Integral Health Asset Management LLC
JPMorgan Chase & Co.
Stempoint Capital LP
Jennison Associates LLC
Candriam S.C.A.
ADAR1 Capital Management LLC
Tema Etfs LLC
In the previous year, these company insiders have bought Mineralys Therapeutics stock:
Brian Taylor Slingsby (Director)
Samsara Biocapital Gp, Llc (Major Shareholder)
Ra Capital Management, LP (Director)
Learn More investors buying Mineralys Therapeutics stock.